Cargando…
The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
Fibroblast growth factor-23 (FGF23) appears to be one of the most promising biomarkers and predictors of cardiovascular risk in patients with heart disease and normal kidney function, but moreover in those with chronic kidney disease (CKD). This review summarizes the current knowledge of FGF23 mecha...
Autores principales: | Figurek, Andreja, Rroji, Merita, Spasovski, Goce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161087/ https://www.ncbi.nlm.nih.gov/pubmed/34065339 http://dx.doi.org/10.3390/cells10051266 |
Ejemplares similares
-
FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
por: Figurek, Andreja, et al.
Publicado: (2023) -
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020) -
Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease
por: Rroji, Merita, et al.
Publicado: (2023) -
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease
por: Rroji, Merita, et al.
Publicado: (2022) -
The renal patient seen by non-renal physicians: the kidney embedded in the ‘milieu intérieur’
por: Perez-Villa, Felix, et al.
Publicado: (2020)